Clinical trial
Effect of Sacubitril-Valsartan on Cardiac Structure and Function in Adults With Congenital Heart Disease
NCT06693674 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Sacubitril-Valsartan on Cardiac Structure and Function in Adults With Congenital Heart Disease
- Lead sponsor
- Mayo Clinic
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- February 3, 2025
- Completion date
- August 31, 2028
- Enrollment
- 45 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
congenital heart disease